secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biofrontera Inc. (BFRI)
CIK:        0001858685
Form:       8-K
Filed at:   2024-06-24T23:59:59+00:00
Accession:  0001493152-24-024881
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biofrontera launches FDA-approved RhodoLED XL lamp for PDT of actinic keratoses
-------------------------------------------------------------------------------

- RhodoLED XL is FDA-approved for use with Ameluz (aminolevulinic acid) for mild-to-moderate actinic keratoses on face and scalp.
- Commercial distribution launched June 10, 2024; first three machines shipped within one week.
- Larger illumination area: five panels vs one on prior lamp; includes positioning sensors for optimal energy delivery.
- First customer Cleaver Dermatology (MO and GA) installed the XL lamp; response from dermatology organizations is positive.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858685/000149315224024881/0001493152-24-024881-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858685/000149315224024881/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-024881

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer